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ABSTRACT
Objectives: Acute kidney damage (Acute kidney injury [AKI]) is defined by elevations in serum creatinine levels that occur after surgery. In cardiac 
surgery, creatinine is a critical determinant. This study highlights the detection of serum creatinine as an early diagnostic and predictive marker of 
AKI following coronary artery bypass grafting (CABG) and to estimate the serum creatinine concentrations before and at 24 and 48 h after CABG.
Methods: It is a single center, Cross-sectional study. Patients from Cardiothoracic and Vascular surgery undergoing CABG in Sri Ramachandra Medical 
College and Research Institute were included in the study. A total of 80 cases were included in the study. The method used for measurement of serum 
creatinine is by modification of kinetic Jaffe reaction. Data were analyzed using Stata/SE version 16.0 and represented in terms of means, standard 
deviation at 95% confidence level and t’ test was performed as statistical analysis and p<0.05 indicates significance. Sigma plot software version 10.0 
was used to draw the standard error mean graphs.
Results: The serum creatinine values at 24 h after the surgery was statistically higher than the preoperative values at 5% significance level (p=0.04). 
The serum creatinine values 48 h after the surgery was also statistically higher than the preoperative values at 1% significance level (p=0.001). The 
serum creatinine values 48 h after surgery are highly significant (p=0.001) when compared to the serum creatinine values 24 h after surgery.
Conclusion: Before an increase in serum creatinine level is detected, over 50% of renal function must be lost. It was concluded that serum creatinine 
is an inadequate and delayed marker of AKI.
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INTRODUCTION
Acute kidney injury (AKI) is described as a sudden decrease in glomerular 
filtration rate (GFR), with clinical symptoms ranging from a little increase 
in blood creatinine to anuric renal failure [1]. The range of injuries varies 
from moderate to advance with renal replacement therapy sometimes. AKI 
affects 7 to 18 percent of hospitalized patients, complicating their courses 
and leading to morbidity or mortality in 50–60% of those hospitalized to an 
Intensive Care Unit (ICU). Although many AKIs are reversible within days to 
weeks of onset, there is evidence of a strong relationship between AKI and 
chronic kidney disease and end-stage renal disease from many substantial 
observational and epidemiologic research over the past decade [2-6]. AKI 
is essentially driven by changes in serum creatinine evels perioperatively. 
In this increasingly common disorder, AKI is largely asymptomatic and is 
nowadays based on functional biomarkers such as serum creatinine and 
blood urea nitrogen [7-9]. Unfortunately, diagnosis of AKI is based on these 
functional biomarkers which are not very specific or sensitive because they 
are affected by many renal and non-renal factors [10].
Obviously, the term for risk of renal failure, kidney damage, kidney 
failure, loss of kidney function and end-stage renal failure (RIFLE), 
AKI Network (AKIN), and Kidney Disease: Enhancing Global Outcomes 
(KDIGO) is used to grade the seriousness of AKI with creatinine [11,12]. 
The primary role of creatinine as a key indicator in risk assessment 
scoring systems is well understood. Creatinine was also used by newer 
prediction scores in the first three major risk factors for mortality 
after cardiac surgery. It has been named AKI-associated cardiac 
surgery because of the distinctive features and conditions of AKI that 
arise after cardiac surgery (Cardiac surgery-associated [CSA]-AKI). At 
present, several studies have been conducted to find answers to key 
questions about the management and cure of perioperative CSA-AKI 
and interesting results have been achieved, particularly in prophylactic 
management [13,14].
For patients undergoing both cardiac surgery and vascular surgery, AKI is 
a common perioperative complication, progressing in 20–70% of cases, 
based on the type of surgery and the description of AKI used [5,15]. 
Coronary Artery Bypass Grafting (CABG) which employs cardiopulmonary 
bypass (CPB) is the utmost usual cause of AKI in the ICU [16,17].
The rise in serum creatinine levels has an important effect on surgical 
outcomes [18]. Also, minor serum creatinine changes that are not large 
enough to be identified as AKI exacerbate the outcome of patients 
undergoing cardiac surgery. Serum creatinine has poor sensitivity and 
has a late response to renal insult. However, due to the simplicity and 
availability of its calculation, serum creatinine levels still constitute the 
key test for the assessment of renal function. Similarly, the core of AKI’s 
consensus concepts is serum creatinine [10].
This study highlights the detection of serum creatinine as an early 
diagnostic and predictive marker of AKI following CABG and to estimate 
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Study population
Patients undergoing CABG in the department of cardiothoracic and 
vascular surgery at Sri Ramachandra Medical College and Research 
Institute. We conducted a cross-sectional study in 80 patients who are 
in the age group of 30–60 years of both sex and who are undergoing 
CABG. The study excluded patients less than 30 years and greater 
than 60 years and with a Pre-existing renal disease, malignancies, and 
patients who have undergone neurological and endocrine surgeries, 
emergency surgeries. Patients who use any Nephrotoxic drugs like 
diuretics, nonsteroidal anti-inflammatory drugs, cyclophosphamide, 
methotrexate, cyclosporine, lithium, pencillamide, gold salts, large doses 
of amphotericin B were also excluded. Institutional Ethics Committee 
clearance approval was obtained before the start of the study (Ref. No: 
CSP-MED/13/DEC/10/136). Each participant was explained about the 
details of the study and informed consent was obtained.
Methodology
Blood samples were drawn from the patients preoperatively and 
postoperatively at 24 h and 48 h for the estimation of serum creatinine. 
The blood samples were collected using BD vacutainer needles into 
yellow topped BD gel vacutainers for serum creatinine estimation. The 
blood samples for serum creatinine were centrifuged at 3000 rpm for 
15 min. The serum was separated and stored in storage vials at −70°C 
until analysis. The method for measurement of serum creatinine is by 
modification of kinetic Jaffe reaction. There is less interference from the 
Jaffe-positive compounds. The procedure was based on the principle 
that strong alkaline medium, picrate reacts with creatinine to form a 
red-colored chromophore. The rate of increasing absorbance at 510 nm 
is due to the formation of this chromophore. It is directly proportional 
to the creatinine concentration in the sample and is measured using 
a bichromatic (510, 600 nm) rate technique. Bilirubin is oxidized by 
potassium ferricyanide to prevent interference. This method is linear 
for Serum Creatinine concentrations up to 20 mg/dl. This method 
has a measurement range of 0.05–20 mg/dl of Serum Creatinine. The 
minimum detection limit by this kit is 0.05 mg/dl. The instrument 
used was Dimension RXL Max. The test conditions involve sample 
size 20 μL, reagent 1 volume 74 μL, reagent 2 volume 18 μL, diluent 
volume 258 μL, test temperature 37°C, wavelength 510 and 600 nm and 
the type of measurement is Bichromatic rate. The reference range of 
serum creatinine values is 0.9–1.3 mg/dl in males and 0.6–1.1 mg/dl 
in females.
Statistical analysis
Data were analyzed using Stata/SE version 16.0 and represented in 
terms of means, standard deviation at 95% confidence level, and t’-test 
was used to determine the p-value and p<0.05 indicates significance. 
Sigma plot software version 10.0 was used to draw the standard error 
mean graphs.
RESULTS
The data consists of 80 observations of patients who had undergone 
CABG. Out of the 80 patients who had undergone CABG, 5 patients had 
on pump and the rest had off pump surgeries as shown in Table 1. Among 
the 80 patients who underwent CABG, 10 were classified under AKI 
category. The criterion used for diagnosis of AKI was the AKIN definition 
and staging criteria (increase in serum creatinine of ≥50% from baseline 
developing over 48 h). Since the sample contains only 13 female patients, 
no analysis was done to determine differences between the two genders.
The serum creatinine values for all the patients were measured thrice, 
once before surgery and twice after surgery (one 24 h and other 48 h 
after surgery). The mean creatinine value pre-operatively for the patients 
without AKI is 0.944 mg/dl. The mean creatinine value pre-operatively 
for the patients with AKI is 1.09 mg/dl. The mean serum creatinine 
value 24 h post-operatively for the patients with out AKI is 0.962 mg/dl. 
The mean creatinine value 24 h postoperatively for the patients with 
AKI is 1.67 mg/dl. The mean creatinine value 48 h post-operatively for 
patients without AKI is 0.902 mg/dl. The mean creatinine value 48 h 
post-operatively for patients with AKI is 3.04 mg/dl. as shown in Table 2. 
Figs. 1-2 showing the mean of creatinine preop and postop (24, 48 h) 
values for patients with AKI or without AKI. Fig. 3 shows the comparison 
graph for the mean of creatinine versus standard error means 
preoperative and postoperative (24, 48 h) values for patients with AKI.
The serum creatinine values at 24 h after the surgery was statistically 
higher than the preoperative values at 5% significance level (p=0.04). 
The serum creatinine values 48 h after the surgery was also statistically 
higher than the preopeartive values at 1% significance level (p=0.001). 
The serum creatinine values 48 h after surgery is highly significant 
(p=0.001) when compared to the serum creatinine values 24 h after 
surgery as shown in Table 3.
DISCUSSION
AKI is a disease that, as indicated by a decreased GFR, and characterized 
by a sudden impairment of kidney function. CSA-AKI results from cardiac 
surgery and percutaneous coronary procedures with extended intensive 
care stays, resulting in either renal injury and/or postoperatively [19,20]. 
AKI after CABG is responsible for high mortality rates; with an incidence 
between 8% and 53% and nearly 1–7% of individuals require dialysis. As 
CABG is a generally accepted and safe treatment for CAD, the incidence 
of AKI in patients who undergo CABG has increased. It is also affected 
by comorbidities due to advancing age [21]. CSA-AKI is associated 
with an increased risk for postoperative complications like infections, 
complicated hospital course, increased short-term and long-term 
mortality [14,22]. Serum creatinine retains the AKI diagnostic standard 
in clinical practice. As per the KDIGO definition, if serum creatinine rises 
within 48 h by 0.3 mg/dl (26.5 μmol/l) or the serum creatinine values 
greater than the baseline in the first 7 days, or if the production of urine 
for 6 h is below 0.5 ml/kg/h, the patient is considered to have AKI [23].
Table 1: Demographic data








On pump 5 (94%)
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Fig. 1: Bar diagram showing the mean of creatinine preop and postop 
(24, 48 hours) values for patients without acute kidney injury
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Even very small increases in serum creatinine have been demonstrated 
to be associated with adverse effects in hospitalized patients over the 
past decade. There is also a substantial decrease in survival due to 
minimal changes in serum creatinine in the postoperative stage [26]. 
Diagnosis of AKI is based generally on either RIFLE or the AKIN criteria 
by monitoring the changes in serum creatinine levels and on the urine 
output [1].
Unfortunately, the serum creatinine levels do not change until 50% of 
the kidney function has been lost and it does not depict kidney function 
until a steady state has been reached. Furthermore, serum creatinine 
levels start to increase 2–4 days after CABG. Due to above-mentioned 
reasons, serum creatinine is considered to be a delayed marker of 
AKI [24]. The identification of reliable biomarkers that allow earlier 
diagnosis of AKI in the postoperative period may increase the success 
of therapeutic interventions [25].
In the present study, the mean serum creatinine values 24 h 
post-operatively in patients who developed AKI was higher than 
that of patients who did not develop AKI. As per the results of 
hypothetical testing in the current study, the postoperative serum 
creatinine values at 24 h after the surgery was statistically higher 
than the preoperative values at 5% significance level (p=0.04). The 
serum creatinine values 48 h after the surgery was statistically higher 
than the pre-operative values at 1% significance level (p=0.001). As 
noticed, the serum creatinine values 48 h after surgery is highly 
significant (p=0.001) when compared to the serum creatinine values 
24 h after surgery. Serum creatinine is an inadequate and delayed 
marker of AKI. More than 50% of the renal function must be lost 
before a rise in serum creatinine level is detected. Unfortunately, 
the diagnostic and staging criteria (RIFLE and AKIN criteria) 
of AKI are based on levels of serum creatinine. By the time renal 
dysfunction is diagnosed by the increase in serum creatinine levels, 
satisfactory clinical intervention is not possible. Even a small rise in 
creatinine level of about 0.2–0.3 mg/dl is associated with increase 
in morbidity and mortality after cardiac surgery. And also, serum 
creatinine is affected by dilutional effect of total body water in the 
early postoperative period.
Wagener et al. [26] found that the serum creatinine levels were 
significantly elevated 48 h after cardiac surgery in adult patients with 
AKI. Serum creatinine is increased by 50% 2–3 days after cardiac surgery 
in children with AKI. Mishra et al. [27] showed that serum creatinine was 
elevated 1–2 days after CABG in children. Bennet et al. [28] showed that 
serum creatinine was significantly elevated 48, 72, and 96 h in children 
who developed AKI after cardiac surgery. Prabhu et al. [29] showed 
increase in creatinine by 50% from baseline occurred at 24 h and 48 h 
after CABG in adult patients. All the above mentioned studies showed 
that serum creatinine increased only 1–3 days after cardiac surgery. In 
this present study also the serum creatinine levels were significantly 
elevated at 48 h (p=0.001) after surgery. Among the 80 patients who 
have undergone CABG, 5 surgeries were done using on-pump technique 
(cardiopulmonary-CPB) and the rest of them were off-pump technique. 
Out of 5 patients who had on-pump CABG, 4 of them have developed 
AKI. CPB is considered to be one of the most important causes of AKI 
in patients undergoing CABG. Increased duration of CPB and aortic 
clamping increase the severity of renal injury. Patients with the bypass 
time greater than 90 min showed more pronounced kidney injury than 
those with bypass time less than 70 min. Several studies have shown 
that off-pump technique is associated with lesser incidence of AKI. In 
this present study, out of 75 patients who underwent off-pump CABG, 
only 6 patients have developed AKI.
Table 2: Descriptive statistics showing the creatinine values
Variable creatinine Mean mg/dl Std. Dev. Std. Err. (95% confidence 
interval)
Patients without AKI pre-operative (n=66) 0.944 0.188 0.023 0.9 0.99
Patient with AKI pre-operative (n=10) 1.09 0.128 0.041 1.01 1.17
Patients without AKI 24 h post-operatrive (n=66) 0.962 0.165 0.118 0.92 1
Patient with AKI 24 h postopeartive (n=10) 1.67 0.189 0.060 1.55 1.79
Patients without AKI 48 h postopeartive (n=66) 0.902 0.214 0.026 0.85 0.95
Patient with AKI 48 h post-opeartive (n=10) 3.04 0.306 0.097 2.85 3.23
AKI: Acute kidney injury
Table 3: Results of creatinine pre‑op and post‑op comparison
Variable 1 Variable 2 p‑value
Creatinine pre-opeartive Creatinine post-operative 24 h 0.04*
Creatinine pre-opeartive Creatinine post-operative 48 h 0.001**
Graph showing the creatinine values (Mean/SEM)
in patients with AKI or Without AKI






































Fig. 3: Graph showing the comparative mean and standard error 
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Fig. 2: Bar diagram showing the mean of creatinine preop and 
postop (24, 48 hours) values for patients with acute kidney injury
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CONCLUSION
The serum creatinine values 48 h after surgery is highly significant 
when compared to the serum creatinine values 24 h after surgery. 
Serum creatinine is an inadequate and delayed marker of AKI. More 
than 50% of the renal function must be lost before a rise in serum 
creatinine level is detected. Even a small rise in creatinine level of 
about 0.2–0.3 mg/dl is associated with increase in morbidity and 
mortality after cardiac surgery. And also, serum creatinine is affected 
by dilutional effect of total body water in the early postoperative 
period. CPB is considered to be one of the most important causes of 
AKI in patients undergoing CABG. Increased duration of CPB and aortic 
clamping increase the severity of renal injury. Patients with the bypass 
time greater than 90 min showed more pronounced kidney injury than 
those with bypass time less than 70 min.
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